SLE syndrome, probably induced by labetalol.
D000974:Antibodies, Antinuclear / Q000032:analysis; D004983:Ethanolamines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007741:Labetalol / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000276:immunology; D008875:Middle Aged
D000974:Antibodies, Antinuclear; D004983:Ethanolamines; D007741:Labetalol